Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry.
Noori S, Wijnands C, Langerhorst P, Bonifay V, Stingl C, Touzeau C, Corre J, Perrot A, Moreau P, Caillon H, Luider TM, Dejoie T, Jacobs JFM, van Duijn MM.
Noori S, et al. Among authors: dejoie t.
Blood Cancer J. 2023 Feb 24;13(1):30. doi: 10.1038/s41408-023-00803-z.
Blood Cancer J. 2023.
PMID: 36828828
Free PMC article.
No abstract available.